P

Inventor

ZHANG WEIXING

CN29 patents
⚠️ This page may combine multiple inventors who share the name “ZHANG WEIXING”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

HOFFMANN LA ROCHE

23 patents
US9447086B2Sep 20, 2016

6-amino acid heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection

HOFFMANN LA ROCHE34 citations93
US9233978B2Jan 12, 2016

6-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection

HOFFMANN LA ROCHE18 citations91
US10428069B2Oct 1, 2019

6-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection

HOFFMANN LA ROCHE6 citations83
US10081627B2Sep 25, 2018

6-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection

HOFFMANN LA ROCHE9 citations83
US9822065B1Nov 21, 2017

Benzazepine dicarboxamide compounds

HOFFMANN LA ROCHE5 citations83
US9597333B2Mar 21, 2017

Benzazepine dicarboxamide compounds

HOFFMANN LA ROCHE10 citations83
US9475775B2Oct 25, 2016

Benzazepine dicarboxamide compounds

HOFFMANN LA ROCHE6 citations83
US9890124B2Feb 13, 2018

Benzazepine sulfonamide compounds

HOFFMANN LA ROCHE5 citations73
US12421252B2Sep 23, 2025

Spiro (isobenzofuranazetidine) compounds for the treatment of autoimmune disease

HOFFMANN LA ROCHE0 citations62
US11713327B2Aug 1, 2023

Heteroaryl heterocyclyl compounds for the treatment of autoimmune disease

HOFFMANN LA ROCHE1 citations62
US11046671B2Jun 29, 2021

Dihydropyrimidinyl benzazepine carboxamide compounds

HOFFMANN LA ROCHE0 citations62
US12351575B2Jul 8, 2025

6-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection

HOFFMANN LA ROCHE0 citations61
US12060333B2Aug 13, 2024

Aminocarbamoyl compounds for the treatment of viral infections

HOFFMANN LA ROCHE1 citations61
US10590112B2Mar 17, 2020

Dihydropyrimidinyl benzazepine carboxamide compounds

HOFFMANN LA ROCHE0 citations52
US12421229B2Sep 23, 2025

Hydropyrido[1,2-α]pyrazine compounds for the treatment of autoimmune disease

HOFFMANN LA ROCHE0 citations51
US12247036B2Mar 11, 2025

Tricyclic compounds for the treatment of cancer

HOFFMANN LA ROCHE0 citations49
US10544102B2Jan 28, 2020

Benzazepine dicarboxamide compounds with secondary amide function

HOFFMANN LA ROCHE0 citations42
US10370338B2Aug 6, 2019

Benzazepine dicarboxamide compounds with tertiary amide function

HOFFMANN LA ROCHE0 citations42
US10428027B2Oct 1, 2019

Sulfinylphenyl or sulfonimidoylphenyl benzazepines

HOFFMANN LA ROCHE0 citations41
US10189838B2Jan 29, 2019

Aza-oxo-indoles for the treatment and prophylaxis of respiratory syncytial virus infection

HOFFMANN LA ROCHE0 citations41
US9890155B2Feb 13, 2018

Aza-oxo-indoles for the treatment and prophylaxis of respiratory syncytial virus infection

HOFFMANN LA ROCHE0 citations41
US9670211B2Jun 6, 2017

Aza-oxo-indoles for the treatment and prophylaxis of respiratory syncytial virus infection

HOFFMANN LA ROCHE0 citations41
US9856247B2Jan 2, 2018

4-methyl-dihydropyrimidines for the treatment and prophylaxis of Hepatitis B virus infection

HOFFMANN LA ROCHE0 citations39

NANJING CANATAL DATA CT ENV TECH CO LTD

2 patents

Mou ben

1 patent

GUO LEI

1 patent

GUANGDONG SHENMA SEARCH TECH CO LTD

1 patent

CHINA NAT RICE RES INST

1 patent